These 2 Top-Rated Stocks Could Be Long-Term Winners

While markets are up this year, by almost 8% on the S&P 500 and more than 15% on the NASDAQ, they remain volatile – and they have yet to recoup all of last year’s losses. The result is an uncertain market environment, one that investors are not quite sure they can trust, even as they want to buy in.

What’s needed here is a reliable tool to find the upwardly mobile stocks, the ones that are primed to win, and to keep winning, in the coming months. That’s where the Smart Score comes in. Based on the TipRanks database, the Smart Score algorithms take the accumulated data points on more than 8,500 publicly traded stocks – and sorts, measures, and combines it. All of the data is evaluated against a set of 8 factors that are known as solid predictors of future share movements.

Eventually, all are combined and recalculated to produce a single score, a number on a scale of 1 to 10, that will indicate where each stock is likely to go from here. Think of the Smart Score as an analytical snapshot of your favorite stocks. One look will tell you the main chance for the near-term.

The Smart Score’s highest rating, the ‘Perfect 10,’ doesn’t necessarily mean that a stock scores high on every metric – but it does mean that the stock in question deserves a closer look. So let’s do just that. We’ve used the TipRanks platform to pull up the details on 2 Perfect 10 stocks, ones with top ratings from the Street and potential to emerge as winners for the long-haul.

Chinook Therapeutics (KDNY)

The first stock we’ll look at is clinical-stage biopharmaceutical company, Chinook Therapeutics. As this firm’s stock ticker suggests, its focus is on diseases of, and treatments for, the kidneys, one of the most vital organ systems of the body, responsible for filtering and cleansing the blood. Chinook is working on several research tracks, with the goal of creating new precision medicines that will address severe kidney diseases with high unmet medical needs.

Story continues

There is a definite market for new kidney medications. The usual treatment for chronic kidney…

..

Read More

Recommended For You

Leave a Reply

Your email address will not be published. Required fields are marked *